The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent - ScienceDirect

$ 25.00

4.5
(671)
In stock
Description

Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease - ScienceDirect

Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease

Nonalcoholic fatty liver disease stratification by liver lipidomics - ScienceDirect

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent - ScienceDirect

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. - Abstract - Europe PMC

Nonalcoholic fatty liver disease stratification by liver lipidomics - ScienceDirect

Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets - ScienceDirect

rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis - ScienceDirect

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease - ScienceDirect

Art 3 Non-Alcoholic Fatty Liver Disease A, PDF, Hepatitis